Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.040
+0.010 (0.49%)
May 19, 2025, 4:00 PM - Market closed
Immutep Market Cap
Immutep has a market cap or net worth of $278.45 million as of May 20, 2025. Its market cap has decreased by -12.93% in one year.
Market Cap
278.45M
Enterprise Value
176.60M
1-Year Change
-12.93%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $278.45M, an increase of 273.25%. That is a compound annual growth rate of 10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 296.90M | -5.81% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |